[Criteria for administration of Lantus, Levemir and Lyrica. Guidelines for administration of Celebra and Arcoxia]
[Article in
Danish]
- PMID: 15672519
Item in Clipboard
[Criteria for administration of Lantus, Levemir and Lyrica. Guidelines for administration of Celebra and Arcoxia]
[Article in
Danish]
Ugeskr Laeger.
.
No abstract available
Comment in
-
[Questions to the Drug Committee about administration of Lyrica].Ugeskr Laeger. 2005 Feb 14;167(7):781-2; discussion 782-3. Ugeskr Laeger. 2005. PMID: 15779268 Danish. No abstract available.
Similar articles
-
[Five years with the Institute of Rational Pharmacotherapy].Ugeskr Laeger. 2005 Jan 10;167(2):169-71. Ugeskr Laeger. 2005. PMID: 15697129 Danish. No abstract available.
-
Rofecoxib (Vioxx) withdrawal: do product monographs adequately inform physicians?Can Fam Physician. 2005 Feb;51(2):212-3. Can Fam Physician. 2005. PMID: 15751564 Free PMC article. No abstract available.
-
[Tick-off-formularies concerning single subsidy of certain drugs--with implemented criteria].Ugeskr Laeger. 2002 Dec 16;164(51):6094-5. Ugeskr Laeger. 2002. PMID: 12553155 Danish. No abstract available.
-
[Five turbulent years of coxibers. Where did the principle of caution go?].Lakartidningen. 2005 May 2-15;102(18-19):1432-4. Lakartidningen. 2005. PMID: 15929426 Review. Swedish. No abstract available.
-
Adverse cardiovascular effects of the coxibs.J Med Chem. 2005 Apr 7;48(7):2251-7. doi: 10.1021/jm0402059. J Med Chem. 2005. PMID: 15801815 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical